Stephan Riedmaier

653 total citations
8 papers, 322 citations indexed

About

Stephan Riedmaier is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Stephan Riedmaier has authored 8 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Pharmacology and 2 papers in Molecular Biology. Recurrent topics in Stephan Riedmaier's work include Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Mitochondrial Function and Pathology (2 papers). Stephan Riedmaier is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Mitochondrial Function and Pathology (2 papers). Stephan Riedmaier collaborates with scholars based in Germany, United States and Denmark. Stephan Riedmaier's co-authors include Ulrich M. Zanger, Kathrin Klein, Ute Hofmann, Matthias Schwab, Jenni E. Keskitalo, Mikko Niemi, Pertti J. Neuvonen, Thomas S. Weiß, Wolfgang E. Thasler and Daniel Knobeloch and has published in prestigious journals such as Free Radical Biology and Medicine, Clinical Pharmacology & Therapeutics and Journal of Proteome Research.

In The Last Decade

Stephan Riedmaier

8 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan Riedmaier Germany 8 129 106 94 75 43 8 322
Aiji Miyashita Japan 11 178 1.4× 127 1.2× 103 1.1× 50 0.7× 72 1.7× 20 451
Kaori Nakamoto United States 5 160 1.2× 122 1.2× 97 1.0× 58 0.8× 23 0.5× 5 359
M. Tabone Italy 17 130 1.0× 126 1.2× 57 0.6× 79 1.1× 48 1.1× 35 892
Noriko Masubuchi Japan 13 142 1.1× 161 1.5× 168 1.8× 52 0.7× 22 0.5× 17 450
Timothy Moeller United States 9 161 1.2× 134 1.3× 69 0.7× 42 0.6× 91 2.1× 10 356
Albert Bilos Netherlands 10 45 0.3× 162 1.5× 103 1.1× 144 1.9× 37 0.9× 14 431
Nobuyuki Murayama Japan 12 136 1.1× 117 1.1× 182 1.9× 36 0.5× 43 1.0× 16 486
Su-Er W. Huskey United States 11 194 1.5× 133 1.3× 127 1.4× 109 1.5× 59 1.4× 13 548
Jin Ah Jung South Korea 11 77 0.6× 85 0.8× 100 1.1× 62 0.8× 41 1.0× 49 409
Maxine Taylor United Kingdom 12 133 1.0× 111 1.0× 83 0.9× 75 1.0× 28 0.7× 14 436

Countries citing papers authored by Stephan Riedmaier

Since Specialization
Citations

This map shows the geographic impact of Stephan Riedmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Riedmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Riedmaier more than expected).

Fields of papers citing papers by Stephan Riedmaier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Riedmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Riedmaier. The network helps show where Stephan Riedmaier may publish in the future.

Co-authorship network of co-authors of Stephan Riedmaier

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Riedmaier. A scholar is included among the top collaborators of Stephan Riedmaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Riedmaier. Stephan Riedmaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Watson, Mark A., Hoi Shan Wong, Pratiksha Dighe, et al.. (2023). Suppression of superoxide/hydrogen peroxide production at mitochondrial site IQ decreases fat accumulation, improves glucose tolerance and normalizes fasting insulin concentration in mice fed a high-fat diet. Free Radical Biology and Medicine. 204. 276–286. 7 indexed citations
2.
Wong, Hoi Shan, Vojtěch Mezera, Pratiksha Dighe, et al.. (2021). Superoxide produced by mitochondrial site IQ inactivates cardiac succinate dehydrogenase and induces hepatic steatosis in Sod2 knockout mice. Free Radical Biology and Medicine. 164. 223–232. 13 indexed citations
3.
Macha, Sreeraj, Regina Sennewald, Noemi Hummel, et al.. (2014). Effect of Gemfibrozil, Rifampicin, or Probenecid on the Pharmacokinetics of the SGLT2 Inhibitor Empagliflozin in Healthy Volunteers. Clinical Therapeutics. 36(2). 280–290.e1. 27 indexed citations
4.
Riedmaier, Stephan, Anke Schnabel, Katrin Marcus, et al.. (2011). A systems biology approach to dynamic modeling and inter-subject variability of statin pharmacokinetics in human hepatocytes. BMC Systems Biology. 5(1). 66–66. 16 indexed citations
5.
Riedmaier, Stephan, Kathrin Klein, Stefan Winter, et al.. (2011). Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis. Frontiers in Pharmacology. 2. 41–41. 42 indexed citations
6.
Klein, Kathrin, Ute Hofmann, Stephan Riedmaier, et al.. (2010). Profiling Induction of Cytochrome P450 Enzyme Activity by Statins Using a New Liquid Chromatography-Tandem Mass Spectrometry Cocktail Assay in Human Hepatocytes. Drug Metabolism and Disposition. 38(9). 1589–1597. 78 indexed citations
7.
Riedmaier, Stephan, Kathrin Klein, Ute Hofmann, et al.. (2009). UDP-Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo. Clinical Pharmacology & Therapeutics. 87(1). 65–73. 84 indexed citations
8.
Zanger, Ulrich M., Stephan Riedmaier, Nicolai Bache, et al.. (2008). Distinction between Human Cytochrome P450 (CYP) Isoforms and Identification of New Phosphorylation Sites by Mass Spectrometry. Journal of Proteome Research. 7(11). 4678–4688. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aiji Miyashita Breakdown of academic impact, for papers by Kaori Nakamoto Breakdown of academic impact, for papers by M. Tabone Breakdown of academic impact, for papers by Noriko Masubuchi Breakdown of academic impact, for papers by Timothy Moeller Breakdown of academic impact, for papers by Albert Bilos Breakdown of academic impact, for papers by Nobuyuki Murayama Breakdown of academic impact, for papers by Su-Er W. Huskey Breakdown of academic impact, for papers by Jin Ah Jung Breakdown of academic impact, for papers by Maxine Taylor
Rankless by CCL
2026